Bionano Genomics Cash from Financing (TTM) Insights

Bionano Genomics Inc (BNGO)

0.95 0.00 (0.00%) USD | NASDAQ | May 03, 16:00

0.9616 +0.01 (+1.22%) Pre-Market: 08:02

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	113.82M
September 30, 2023	45.48M
June 30, 2023	55.54M
March 31, 2023	37.86M
December 31, 2022	23.01M
September 30, 2022	24.83M
June 30, 2022	15.94M
March 31, 2022	-1.418M
December 31, 2021	336.11M
September 30, 2021	365.83M
June 30, 2021	367.15M
March 31, 2021	400.57M
December 31, 2020	61.90M

Date	Value
September 30, 2020	48.71M
June 30, 2020	33.84M
March 31, 2020	18.39M
December 31, 2019	30.38M
September 30, 2019	11.86M
June 30, 2019	30.90M
March 31, 2019	33.31M
December 31, 2018	35.78M
September 30, 2018	37.28M
June 30, 2018	20.92M
March 31, 2018	23.96M
December 31, 2017	17.61M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-1.418M

Minimum

Mar 2022

400.57M

Maximum

Mar 2021

106.35M

Average

37.86M

Median

Mar 2023

Cash from Financing (TTM) Benchmarks